Growth Metrics

Novanta (NOVT) EPS (Weighted Average and Diluted) (2016 - 2026)

Novanta filings provide 14 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.51 for Q2 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 13.56% to $0.51 in Q2 2026 year-over-year; TTM through Apr 2026 was $1.39, a 28.72% decrease, with the full-year FY2025 number at $1.47, down 16.95% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.51 in Q2 2026 for Novanta, up from $0.46 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.63 in Q3 2022 to a low of $0.12 in Q2 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.49 (2022), compared with a mean of $0.46.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 65.79% in 2022 and later plummeted 68.42% in 2025.
  • Novanta's EPS (Weighted Average and Diluted) stood at $0.42 in 2022, then dropped by 19.05% to $0.34 in 2023, then soared by 32.35% to $0.45 in 2024, then grew by 2.22% to $0.46 in 2025, then rose by 10.87% to $0.51 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.51 (Q2 2026), $0.46 (Q4 2025), and $0.3 (Q3 2025) per Business Quant data.